4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-25-079022
Director sold 5,000 shares at $126.45 ($632,250)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Basile Edward M · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $0.70 | $3,500 | 7,866 | D |
| 2025-05-27 | Sale : show line 2 in the form 10b5-1 | −5,000 | $126.45 | $632,250 | 2,866 | D |
| Open-market sales · 5,000 sh · avg $126.45 · $632,250 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-27 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −5,000 | 8,285 | D |
Loading xslF345X05/ownership.xml…